1. Home
  2. ANVS vs IZEA Comparison

ANVS vs IZEA Comparison

Compare ANVS & IZEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • IZEA
  • Stock Information
  • Founded
  • ANVS 2008
  • IZEA 2006
  • Country
  • ANVS United States
  • IZEA United States
  • Employees
  • ANVS N/A
  • IZEA N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • IZEA Advertising
  • Sector
  • ANVS Health Care
  • IZEA Consumer Discretionary
  • Exchange
  • ANVS Nasdaq
  • IZEA Nasdaq
  • Market Cap
  • ANVS 44.6M
  • IZEA 44.6M
  • IPO Year
  • ANVS 2020
  • IZEA N/A
  • Fundamental
  • Price
  • ANVS $2.67
  • IZEA $3.29
  • Analyst Decision
  • ANVS Strong Buy
  • IZEA
  • Analyst Count
  • ANVS 4
  • IZEA 0
  • Target Price
  • ANVS $18.00
  • IZEA N/A
  • AVG Volume (30 Days)
  • ANVS 433.2K
  • IZEA 53.4K
  • Earning Date
  • ANVS 08-14-2025
  • IZEA 08-13-2025
  • Dividend Yield
  • ANVS N/A
  • IZEA N/A
  • EPS Growth
  • ANVS N/A
  • IZEA N/A
  • EPS
  • ANVS N/A
  • IZEA N/A
  • Revenue
  • ANVS N/A
  • IZEA $36,896,490.00
  • Revenue This Year
  • ANVS N/A
  • IZEA $22.24
  • Revenue Next Year
  • ANVS N/A
  • IZEA N/A
  • P/E Ratio
  • ANVS N/A
  • IZEA N/A
  • Revenue Growth
  • ANVS N/A
  • IZEA 7.17
  • 52 Week Low
  • ANVS $1.11
  • IZEA $1.68
  • 52 Week High
  • ANVS $13.91
  • IZEA $3.29
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 57.27
  • IZEA 74.41
  • Support Level
  • ANVS $2.63
  • IZEA $2.55
  • Resistance Level
  • ANVS $2.97
  • IZEA $3.15
  • Average True Range (ATR)
  • ANVS 0.25
  • IZEA 0.16
  • MACD
  • ANVS 0.03
  • IZEA 0.07
  • Stochastic Oscillator
  • ANVS 82.61
  • IZEA 98.97

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

Share on Social Networks: